Edward H. Kaplan, MD & Associates

Skokie, Illinois 60076

0 studies enrolling now · 12 studies all time

What they study most

Acute Lymphoblastic Leukemia, Adult B-Cell, Cancer of the Lung, Carcinoma, Chemotherapy-induced Nausea and Vomiting, Chronic Lymphocytic Leukemia, Chronic Myelomonocytic Leukemia, Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer, Leukemia, Myeloid, Acute, Lung Neoplasms, MDS

Studies at this site

• A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) — Running, not enrolling
• Connect® Myeloid Disease Registry — Stopped early
• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed
• Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting — Completed
• The clonoSEQ® Watch Registry — Stopped early
• Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC — Status unconfirmed
• BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma — Completed
• A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer — Completed
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
• A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer — Completed
• Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer — Completed
• A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study — Stopped early